Assessment of insulin-like growth factors and mutagen sensitivity as predictors of lung cancer risk

Methods Mol Med. 2003:75:279-87. doi: 10.1385/1-59259-324-0:279.
No abstract available

MeSH terms

  • 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide / pharmacology
  • Bleomycin / pharmacology
  • Chromatids / pathology
  • Chromosome Aberrations
  • Enzyme-Linked Immunosorbent Assay / methods
  • Humans
  • Insulin-Like Growth Factor Binding Protein 3 / blood*
  • Insulin-Like Growth Factor I / analysis*
  • Insulin-Like Growth Factor II / analysis*
  • Lung Neoplasms / blood*
  • Lung Neoplasms / diagnosis
  • Lymphocytes / drug effects
  • Lymphocytes / metabolism
  • Mutagenicity Tests
  • Mutagens / pharmacology*
  • Predictive Value of Tests
  • Risk Factors

Substances

  • Insulin-Like Growth Factor Binding Protein 3
  • Mutagens
  • Bleomycin
  • 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide
  • Insulin-Like Growth Factor I
  • Insulin-Like Growth Factor II